Saniva diagnostics GmbH is a German medical technology company founded in 2019 in the field of diagnostics, based in Erfurt (Germany). The company, which originated as a spin-off of the University Hospital Jena, is the patent holder researching and developing a motor screening instrument for the early detection of neurodegenerative diseases.

The timing of diagnosis has a decisive influence on the treatment and chances of cure from diseases. While numerous preventive examinations are offered for cancer and cardiovascular diseases, no such preventive examinations are currently available for neurodegenerative diseases (e.g., Parkinson’s disease or Alzheimer’s disease). Neurodegenerative diseases are increasing with demographic change, and therefore represent the major health economic challenges of current and future times. At the time of clinical symptom manifestation, the neurodegenerative process is already irreversibly advanced, although the actual disease manifestation is preceded by a long preliminary phase (prodromal phase) of the disease. In this preliminary phase, mild motor abnormalities (MMA) may already occur, but are not detectable with currently used tests and instruments.

Jenny Nisser

CEO | Founder
Scientific Director 

Sport Science | Research and development | Clinical Studies | Intellectual Property (IP)

Matthias Bohn

Project Manager
Business Development | Regulatory Affairs

Ines Ebner

Scientific Associate
Sport Science | Research and development